Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
Ther Adv Neurol Disord
; 14: 17562864211012835, 2021.
Article
em En
| MEDLINE
| ID: mdl-34035836
Texto completo:
1
Bases de dados:
MEDLINE
Idioma:
En
Revista:
Ther Adv Neurol Disord
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Israel